These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [THE MYELOPROLIFERATIVE SYNDROME FROM THE VIEWPOINT OF CLINICAL HEMATOLOGISTS]. KUNZ G Z Gesamte Inn Med; 1964 Dec; 19():SUPPL:194-7. PubMed ID: 14235899 [No Abstract] [Full Text] [Related]
5. POLYCYTHAEMIA VERA: A CASE REPORT. JACOBS P Cent Afr J Med; 1963 Oct; 9():387-95. PubMed ID: 14066238 [No Abstract] [Full Text] [Related]
7. [THE PLACE OF OSTEOMYELOSCLEROSIS AMONG THE MYELOPROLIFERATIVE DISEASES]. STOBBE H Dtsch Gesundheitsw; 1965 Jan; 20():13-20. PubMed ID: 14265017 [No Abstract] [Full Text] [Related]
8. [Relation of polycythemia vera (Vaquez' disease) to myelosclerosis and leukosis. Polycythemia vera and so-called myeloproliferative states]. MAYER G; MAYER S; WAITZ R Rev Prat; 1962 Sep; 12():2399-410. PubMed ID: 13934120 [No Abstract] [Full Text] [Related]
9. MYELOPROLIFERATIVE SYNDROME; EVALUATION OF MYELOSCLEROSIS AND CHRONIC MYELOGENOUS LEUKEMIA TO POLYCYTHEMIA VERA. LOPAS H; JOSEPHSON AM Arch Intern Med; 1964 Dec; 114():754-9. PubMed ID: 14211587 [No Abstract] [Full Text] [Related]
10. STANDARDIZATION OF THE LEUKOCYTE ALKALINE PHOSPHATASE TEST. II. REPORT OF CLINICAL STUDIES. KNUDTSON KP; EVANGER AE; STEVENS AR Am J Clin Pathol; 1964 Aug; 42():121-4. PubMed ID: 14202142 [No Abstract] [Full Text] [Related]
11. [Novel method in diagnosis of chronic myeloproliferative disorders--detection of JAK2 mutation]. Rajnai H; Bödör C; Reiniger L; Timár B; Csernus B; Szepesi A; Csomor J; Matolcsy A Orv Hetil; 2006 Nov; 147(45):2175-9. PubMed ID: 17402211 [TBL] [Abstract][Full Text] [Related]
12. Biochemical studies in chronic myelocytic leukemia, polycythemia vera and other idiopathic myeloproliferative disorders. VALENTINE WN; BECK WS; FOLLETTE JH; MILLS H; LAWRENCE JS Blood; 1952 Oct; 7(10):959-77. PubMed ID: 12977828 [No Abstract] [Full Text] [Related]
13. [Familial myeloproliferative syndromes. Study of 6 families and review of literature]. Kaufman S; Brière J; Bernard J Nouv Rev Fr Hematol (1978); 1978 Apr; 20(1):1-15. PubMed ID: 353725 [TBL] [Abstract][Full Text] [Related]
14. Polycythemia vera: its course and treatment; relation to myeloid metaplasia and leukemia. WASSERMAN LR Bull N Y Acad Med; 1954 May; 30(5):343-75. PubMed ID: 13150002 [No Abstract] [Full Text] [Related]
15. [The treatment of myeloproliferative syndromes]. Maurice P Schweiz Med Wochenschr; 1975 Oct; 105(40):1269-74. PubMed ID: 1061995 [TBL] [Abstract][Full Text] [Related]
16. [CAN A POLYCYTHEMIA VERA TURN INTO CHRONIC MYELOIC LEUKEMIA?]. BRAUNSTEINER H; ROTHENBUCHNER G; SCHOBER B Med Klin; 1964 Apr; 59():614-8. PubMed ID: 14199975 [No Abstract] [Full Text] [Related]
17. [PRE-LEUKEMIC POLYCYTHEMIA OF WEIL AND CAHEN]. DELLACQUA G Rass Clin Ter; 1964; 63():77-92. PubMed ID: 14153006 [No Abstract] [Full Text] [Related]
19. Treatment of myeloproliferative diseases. Sellei C Ther Hung; 1966; 14(4):135-6. PubMed ID: 5228101 [No Abstract] [Full Text] [Related]
20. [THE MYELOPROLIFERATIVE SYNDROME FROM THE VIEWPOINT OF THE PATHOLOGIST]. BOLCK F Z Gesamte Inn Med; 1964 Dec; 19():SUPPL:193-4 F. PubMed ID: 14235898 [No Abstract] [Full Text] [Related] [Next] [New Search]